Directory
>
Kevin Bitterman
Kevin Bitterman
Board Chair | Isabella Stewart Gardner Museum
Cambridge, Massachusetts, United States
Kevin Bitterman
Summary
Kevin Bitterman is a seasoned venture partner at Atlas Venture, specializing in the life sciences sector. With a robust academic background, including a Ph.D. in Genetics from Harvard Medical School, he has a deep understanding of biochemistry, biotechnology, and drug development. Kevin has held numerous leadership roles on the boards of various biotech companies, showcasing his strategic insight and commitment to innovation in healthcare. His extensive experience spans over two decades in the pharmaceutical industry, where he has been instrumental in guiding startups and established firms alike. Kevin's passion for advancing medical technology is evident in his work with companies focused on drug discovery and clinical trials. He is also actively involved in the venture capital community, contributing to the growth of emerging technologies. Kevin's diverse experiences in both corporate and startup environments highlight his adaptability and forward-thinking approach. He is known for fostering collaboration between scientific research and commercialization, making significant impacts in the biopharmaceutical landscape.
Kevin Bitterman
Work Experience
Board Chair at
Chroma Medicine Securities Corporation
December 2020 - Present
Board of Directors at
KINASET THERAPEUTICS LTD
June 2020 - Present
Board of Directors at
Remix Therapeutics
June 2019 - Present
Board Of Directors at
Disc Medicine
November 2017 - Present
Partner at
Atlas Venture
June 2017 - Present
Advisory Board Member at
Isabella Stewart Gardner Museum
May 2017 - Present
Board of Directors at
Mariana Oncology
March 2021 - May 2024
Board Member at
New England Venture Capital Association
August 2013 - August 2023
Board of Directors at
Akero Therapeutics
June 2018 - December 2021
Board of Directors at
Navitor Pharmaceuticals
July 2017 - June 2020
Board of Directors at
Editas Medicine
June 2014 - June 2018
Board of Directors at
Neuronetics
January 2011 - June 2017
Board of Directors at
Vets First Choice
April 2012 - June 2017
Board of Directors at
Morphic Therapeutic
July 2015 - June 2017
Partner at
Polaris Partners
July 2004 - June 2017
Board of Directors at
KALA BIO
January 2009 - May 2017
Board of Directors at
Taris Biomedical
January 2008 - May 2017
Board of Directors at
Genocea Biosciences, Inc.
January 2006 - February 2017
Founding CEO at
Morphic Therapeutic
October 2014 - July 2015
Board of Directors at
Visterra Inc.
January 2009 - April 2015
Founding CEO at
Editas Medicine
July 2013 - June 2014
Kevin Bitterman
Education
Harvard Medical School, Ph.D.
January 1999 - January 2004
Rutgers University, Ba
January 1995 - January 1999
Frequently Asked Questions about Kevin Bitterman
What is Kevin Bitterman email address?
Kevin Bitterman's primary email address is **********@atlasventure.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kevin Bitterman work for?
Kevin Bitterman is a Board Chair at Isabella Stewart Gardner Museum, a company specializing in Amusement & recreation, nec.
Where Kevin Bitterman graduated from?
Kevin Bitterman holds a degree in Genetics from Harvard Medical School.
How can I directly contact Kevin Bitterman?
To contact Kevin Bitterman directly, you can use the email address **********@atlasventure.com. Complete contact information is available upon registration with Muraena.
Who is Kevin Bitterman?
Kevin Bitterman is a seasoned venture partner at Atlas Venture, specializing in the life sciences sector. With a robust academic background, including a Ph.D. in Genetics from Harvard Medical School, he has a deep understanding of biochemistry, biotechnology, and drug development. Kevin has held numerous leadership roles on the boards of various biotech companies, showcasing his strategic insight and commitment to innovation in healthcare. His extensive experience spans over two decades in the pharmaceutical industry, where he has been instrumental in guiding startups and established firms alike. Kevin's passion for advancing medical technology is evident in his work with companies focused on drug discovery and clinical trials. He is also actively involved in the venture capital community, contributing to the growth of emerging technologies. Kevin's diverse experiences in both corporate and startup environments highlight his adaptability and forward-thinking approach. He is known for fostering collaboration between scientific research and commercialization, making significant impacts in the biopharmaceutical landscape.
Kevin`s contact details
**********@atlasventure.com
**@polaris.vc
**@polarispartners.com
Colleagues
President of the Board of Trustees
Instructor
Chief Financial and Administrative Officer